Pacific Edge on growth track, despite US pay concerns

Pacific Edge on growth track, despite US pay concerns
Peter Meintjes says the team has expanded to 100. (Image: Supplied)
Staff reporters
Pacific Edge says throughput of its Cxbladder tests across both its New Zealand and US labs jumped by 36% year-on-year to 7,861 tests for the third quarter. In its September quarter update, the cancer diagnostics firm, which is listed on the NZ stock exchange, said processing was also up 11% on the quarter before, with total processing coming in at 14,916 tests across its labs for the six months to September 2022.Chief executive Peter Meintjes said the Dunedin-based company had made progress in the NZ market, with general practitioners in...